Lorie Anne Brown, ARNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 450 Gibner Rd, Dunham Us Army Health Clinic, Carlisle Barracks, PA 17013 Phone: 717-245-3041 Fax: 717-245-3815 |
Ms. Christina Kendall Eshelman, NURSE PRACTITIONER Nurse Practitioner - Women's Health Medicare: Medicare Enrolled Practice Location: 450 Gibner Rd, Dunham Us Army Health Clinic, Carlisle Barracks, PA 17013 Phone: 717-245-3334 Fax: 717-245-3880 |
Mrs. Jane A Weber, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 450 Gibner Rd, Carlisle Barracks, PA 17013 Phone: 717-245-4774 Fax: 717-245-3776 |
News Archive
A large group of family medicine researchers, educators and clinicians propose a framework of definitions to clarify the similarities, differences and relationships between common terms used by those involved in population health, community health and public health. They write that shared language must be clear enough to help and not hinder people working together as they come to a mutual understanding of roles, responsibilities and actions in their joint work.
Two-thirds of women who donated eggs to fertility clinics reported satisfaction with the process, but 16 percent complained of subsequent physical symptoms and 20 percent reported lasting psychological effects, according to the first study to examine the long-term effects of donation.
Physicians can reduce the number of heart failure deaths and unnecessary hospital admissions by using a new computer-based algorithm developed at the Institute for Clinical Evaluative Sciences (ICES) that calculates each patient's individual risk of death. Published in the Annals of Internal Medicine, the algorithm improves upon clinical decision-making and determines whether or not a patient with heart failure should be admitted to hospital.
Ember Therapeutics, Inc., a privately held, New York-based biopharmaceutical company that is developing targeted therapies for osteoarthritis, kidney fibrosis, and other indications using Bone Morphogenetic Protein (BMP)-7, announced today initial results from the Phase II(a) trial of local BMP-7 administration in patients with moderate osteoarthritis of the knee.
› Verified 7 days ago